[Human papilloma virus (HPV) antigens and DNA in dysplasia and carcinoma of the uterine cervix].
Routinely paraffin-embedded sections of dysplasia, carcinoma in situ (CIS) and invasive (squamous) carcinoma of the cervix were studied to determine the participation of human papilloma virus (HPV) in these tissues. Morphological observation (1,059 cases) revealed condylomatous changes to reach 54% in dysplasia, 25% in CIS and 25% in invasive carcinoma. Condylomatous changes were also found to be 25 to 40% in the non-cancerous epithelia adjacent to in situ or invasive carcinomas. The immuno-peroxidase-PAP-method using anti-HPV serum was applied to 98 selected sections in which condylomatous changes were morphologically observed. HPV antigens were found to reach 56% in dysplasia, 42% in CIS and 35% in invasive carcinoma, and this result suggested that the morphologically observed condylomatous changes did not always coincide with virus maturation in the infected cells. By means of the in situ hybridization technique, HPV type-6, -11, -16 and -18 DNAs were all detected in dysplasia sections, whereas HPV type-16 DNA was demonstrated distinctively at a high rate among in situ and invasive carcinomas.
Yamagata
S
S
Department of Obstetrics and Gynecology, Osaka City University Medical School.
Tsuchida
S
S
Yamamoto
K
K
Kawamura
N
N
Nakamura
T
T
Ueki
S
S
Sugawa
T
T
D000956:Antigens, Viral / Q000032:analysis*; D002278:Carcinoma in Situ / Q000032:analysis / Q000276:immunology / Q000473:pathology; D002294:Carcinoma, Squamous Cell / Q000032:analysis / Q000276:immunology / Q000473:pathology; D003218:Condylomata Acuminata / Q000473:pathology; D004279:DNA, Viral / Q000032:analysis*; D004848:Epithelium / Q000032:analysis / Q000276:immunology; D005260:Female; D006801:Humans; D007124:Immunoenzyme Techniques; D009693:Nucleic Acid Hybridization; D027383:Papillomaviridae / Q000145:classification / Q000235:genetics / Q000276:immunology*; D014412:Tumor Virus Infections / Q000276:immunology / Q000378:metabolism / Q000473:pathology; D002578:Uterine Cervical Dysplasia / Q000032:analysis / Q000276:immunology* / Q000473:pathology; D002583:Uterine Cervical Neoplasms / Q000032:analysis / Q000276:immunology* / Q000473:pathology
D000956:Antigens, Viral; D004279:DNA, Viral